New Delhi: Indian drug makers that have created a niche in the global market with cheap copycat versions of off-patent medicines are concerned about the fallout from a US investigation of Ranbaxy Laboratories Ltd for alleged fraudulent conduct.
The details can be read here.
No comments:
Post a Comment